Welcome to our dedicated page for Retractable Tech SEC filings (Ticker: RVP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Retractable Technologies, Inc. filings document the regulatory record for a Texas medical device manufacturer whose common stock trades on NYSE American under RVP. Recent Form 8-K reports cover material events such as operating-results releases, workforce reductions, product designation announcements, and dividends on Series II and Series III Class B Convertible Preferred Stock.
The company’s proxy materials disclose annual meeting matters, director elections, board structure, shareholder voting procedures, and executive-governance information. Together, the filings describe Retractable’s public-company capital structure, recurring event disclosures, governance processes, and formal exhibits tied to its safety medical products business.
Retractable Technologies, Inc. (RVP) – Form 4 insider transaction
President, CEO, Director and 10% owner Thomas J. Shaw reported an open-market purchase (transaction code P) of company common stock on 30 June 2025. Shaw acquired 1,347 shares at a weighted-average price of $0.6221 per share pursuant to a Rule 10b5-1 trading plan adopted on 22 Aug 2024.
- Direct ownership after the trade: 15,442,020 shares
- Indirect ownership (trust & voting agreement): 831,600 shares
- Total reported beneficial ownership (direct + indirect): 16,273,620 shares
No derivative securities were reported in Table II. The filing indicates Shaw remains a key insider (Director, CEO, 10% holder) and the form was signed on 1 July 2025.